Recombinant human insulin-like growth factor I (rhIGF-I) for the treatment of amyotrophic lateral sclerosis/motor neuron disease.

Cochrane database of systematic reviews (Online)

Volumn 11, Issue , 2012, Pages

  Beauverd, Michel ^a   Mitchell, J D ^b   Wokke, John H J ^b   Borasio, Gian Domenico ^b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT PROTEIN; SOMATOMEDIN C;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; DISEASE COURSE; HUMAN; MALE; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEVERITY OF ILLNESS INDEX;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; DISEASE PROGRESSION; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECOMBINANT PROTEINS; SEVERITY OF ILLNESS INDEX;

EID: 84872197429     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: None     Document Type: Review

References (0)